From 26^th to 27^th August 2022, the “11^th Asia Pharma R&D Leaders 2022”, which is organized by Shine Consultant International, supported by Chinese Biopharmaceutical Association - USA, Korea Biotechnology Industry Organisation, The BayHelix Group and Takeda Development Center Asia, is convened in Shanghai.

The event features 6 panel discussion centering “Early research & translational medicine”, “Clinical development & global registration”, “R&D of antibody drug”, “R&D of small molecule drug”, “Cell & gene therapy” and “Investment, financing & external innovation”.

Themed “Clinic-oriented & patient-centered drug R&D and Innovation”, the event attracts participants from multinational pharmaceutical corporations, Chinese pharmaceutical giants, biopharma corporations and research institutes from home and abroad.

Wanhuida Intellectual Property sets up a booth at the summit. The firm’s Partners Hu Honghui and Xie Minnan, Associate Guan Yue, Attorney Zhang Xiaoquan and Patent Attorney Qiu Zhongkuang attend the summit.

Guan Yue talking to a visitor of Wanhuida booth

Guan Yue, Qiu Zhongkuang, Xie Minnan & Hu Honghui at the firm’s booth